ARCHIVES

NCI disclosure of walk-out by Data and Safety Monitoring Board of the National Lung Screening Trial may be harmful, improper, experts say.

This article is from The Cancer Letter archive.

Vol. 30 No. 16 | April 16, 2004

Download PDF Visit The Full Archive

Related Articles

Senate Increases NIH Funding for 2013, Rejects President’s $200+ Million Increase for Program Evaluation Activities

June 22, 2012

In Brief: House Budget Committee Proposes 5% Cut To NIH In FY96; Steady Reductions Expected

March 24, 1995

RFAs: Patient Outcomes “5-A-Day” Program

April 10, 1992

1981 Budget By Funding Mechanism

June 1, 1979

Drug Development Gets Extra $500,000

November 18, 1977

Beth Israel Suspends Enrollment In Trials Following An Audit

October 22, 2010